These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 15901802

  • 1. Delineation of human peptide transporter 1 (hPepT1)-mediated uptake and transport of substrates with varying transporter affinities utilizing stably transfected hPepT1/Madin-Darby canine kidney clones and Caco-2 cells.
    Bhardwaj RK, Herrera-Ruiz D, Sinko PJ, Gudmundsson OS, Knipp G.
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1093-100. PubMed ID: 15901802
    [Abstract] [Full Text] [Related]

  • 2. Interactions of a nonpeptidic drug, valacyclovir, with the human intestinal peptide transporter (hPEPT1) expressed in a mammalian cell line.
    Guo A, Hu P, Balimane PV, Leibach FH, Sinko PJ.
    J Pharmacol Exp Ther; 1999 Apr; 289(1):448-54. PubMed ID: 10087037
    [Abstract] [Full Text] [Related]

  • 3. Effect of ionization on the variable uptake of valacyclovir via the human intestinal peptide transporter (hPepT1) in CHO cells.
    Balimane P, Sinko P.
    Biopharm Drug Dispos; 2000 Jul; 21(5):165-74. PubMed ID: 11180195
    [Abstract] [Full Text] [Related]

  • 4. A novel hPepT1 stably transfected cell line: establishing a correlation between expression and function.
    Herrera-Ruiz D, Faria TN, Bhardwaj RK, Timoszyk J, Gudmundsson OS, Moench P, Wall DA, Smith RL, Knipp GT.
    Mol Pharm; 2004 Jul; 1(2):136-44. PubMed ID: 15832510
    [Abstract] [Full Text] [Related]

  • 5. Cellular uptake mechanism of amino acid ester prodrugs in Caco-2/hPEPT1 cells overexpressing a human peptide transporter.
    Han HK, Oh DM, Amidon GL.
    Pharm Res; 1998 Sep; 15(9):1382-6. PubMed ID: 9755889
    [Abstract] [Full Text] [Related]

  • 6. Peptide transporter substrate identification during permeability screening in drug discovery: comparison of transfected MDCK-hPepT1 cells to Caco-2 cells.
    Balimane PV, Chong S, Patel K, Quan Y, Timoszyk J, Han YH, Wang B, Vig B, Faria TN.
    Arch Pharm Res; 2007 Apr; 30(4):507-18. PubMed ID: 17489369
    [Abstract] [Full Text] [Related]

  • 7. Ibuprofen is a non-competitive inhibitor of the peptide transporter hPEPT1 (SLC15A1): possible interactions between hPEPT1 substrates and ibuprofen.
    Omkvist DH, Brodin B, Nielsen CU.
    Br J Pharmacol; 2010 Dec; 161(8):1793-805. PubMed ID: 20726987
    [Abstract] [Full Text] [Related]

  • 8. Direct evidence for peptide transporter (PepT1)-mediated uptake of a nonpeptide prodrug, valacyclovir.
    Balimane PV, Tamai I, Guo A, Nakanishi T, Kitada H, Leibach FH, Tsuji A, Sinko PJ.
    Biochem Biophys Res Commun; 1998 Sep 18; 250(2):246-51. PubMed ID: 9753615
    [Abstract] [Full Text] [Related]

  • 9. Dipeptide model prodrugs for the intestinal oligopeptide transporter. Affinity for and transport via hPepT1 in the human intestinal Caco-2 cell line.
    Nielsen CU, Andersen R, Brodin B, Frokjaer S, Taub ME, Steffansen B.
    J Control Release; 2001 Sep 11; 76(1-2):129-38. PubMed ID: 11532319
    [Abstract] [Full Text] [Related]

  • 10. The apical (hPepT1) and basolateral peptide transport systems of Caco-2 cells are regulated by AMP-activated protein kinase.
    Pieri M, Christian HC, Wilkins RJ, Boyd CA, Meredith D.
    Am J Physiol Gastrointest Liver Physiol; 2010 Jul 11; 299(1):G136-43. PubMed ID: 20430871
    [Abstract] [Full Text] [Related]

  • 11. Drug inhibition of Gly-Sar uptake and hPepT1 localization using hPepT1-GFP fusion protein.
    Sun D, Landowski CP, Chu X, Wallsten R, Komorowski TE, Fleisher D, Amidon GL.
    AAPS PharmSci; 2001 Jul 11; 3(1):E2. PubMed ID: 11741253
    [Abstract] [Full Text] [Related]

  • 12. Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity.
    Taub ME, Podila L, Ely D, Almeida I.
    Drug Metab Dispos; 2005 Nov 11; 33(11):1679-87. PubMed ID: 16093365
    [Abstract] [Full Text] [Related]

  • 13. Interactions of amoxicillin and cefaclor with human renal organic anion and peptide transporters.
    Li M, Anderson GD, Phillips BR, Kong W, Shen DD, Wang J.
    Drug Metab Dispos; 2006 Apr 11; 34(4):547-55. PubMed ID: 16434549
    [Abstract] [Full Text] [Related]

  • 14. Construction, identification and application of HeLa cells stably transfected with human PEPT1 and PEPT2.
    Guo X, Meng Q, Liu Q, Wang C, Sun H, Kaku T, Liu K.
    Peptides; 2012 Apr 11; 34(2):395-403. PubMed ID: 22369721
    [Abstract] [Full Text] [Related]

  • 15. Functional characterization of sodium-dependent multivitamin transporter in MDCK-MDR1 cells and its utilization as a target for drug delivery.
    Luo S, Kansara VS, Zhu X, Mandava NK, Pal D, Mitra AK.
    Mol Pharm; 2006 Apr 11; 3(3):329-39. PubMed ID: 16749865
    [Abstract] [Full Text] [Related]

  • 16. Recognition and transport characteristics of nonpeptidic compounds by basolateral peptide transporter in Caco-2 cells.
    Irie M, Terada T, Sawada K, Saito H, Inui K.
    J Pharmacol Exp Ther; 2001 Aug 11; 298(2):711-7. PubMed ID: 11454935
    [Abstract] [Full Text] [Related]

  • 17. CHO/hPEPT1 cells overexpressing the human peptide transporter (hPEPT1) as an alternative in vitro model for peptidomimetic drugs.
    Han HK, Rhie JK, Oh DM, Saito G, Hsu CP, Stewart BH, Amidon GL.
    J Pharm Sci; 1999 Mar 11; 88(3):347-50. PubMed ID: 10052994
    [Abstract] [Full Text] [Related]

  • 18. Comparison of bidirectional cephalexin transport across MDCK and caco-2 cell monolayers: interactions with peptide transporters.
    Putnam WS, Pan L, Tsutsui K, Takahashi L, Benet LZ.
    Pharm Res; 2002 Jan 11; 19(1):27-33. PubMed ID: 11837697
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.